Translational science, biomarkers, and antibodies in spondyloarthritis

In this episode of Arthritis At Home, we are excited to raise awareness for World AS Day (happening on May 2) by sharing the #CRArthritis 2026 interview with Dr. Walter Maksymowych, a Professor in the Department of Medicine and Dentistry at the University of Alberta. World AS Day is an annual day dedicated to people living with axial spondyloarthritis. Dr. Walter Maksymowych defines what biomarkers are and why it is so important in the diagnosis of spondyloarthritis. Biomarkers can also be an indicator of something that is happening inside the body. Dr. Maksymowych concludes by highlighting some key points from his workshop on translational science. About Dr. Walter Maksymowych Dr. Walter Maksymowych is a Professor in the Department of Medicine and Dentistry at the University of Alberta. He is a co-founder and principal investigator at the Spondyloarthritis Research Consortium of Canada (SPARCC), a group established to develop biomarkers and imaging technologies for this form of spinal arthritis. Additional learning resourcesJointHealth™ Education – Ankylosing Spondylitis Spondyloarthritis Research Consortium of CanadaArthritis Consumer Experts’ About Axial Spondyloarthritis page